Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 2
2005 2
2006 2
2007 1
2009 1
2010 3
2011 6
2012 1
2013 1
2014 3
2015 3
2016 2
2017 3
2018 3
2019 11
2020 8
2021 2
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
NK cells and ILCs in tumor immunotherapy.
Sivori S, Pende D, Quatrini L, Pietra G, Della Chiesa M, Vacca P, Tumino N, Moretta F, Mingari MC, Locatelli F, Moretta L. Sivori S, et al. Mol Aspects Med. 2021 Aug;80:100870. doi: 10.1016/j.mam.2020.100870. Epub 2020 Aug 13. Mol Aspects Med. 2021. PMID: 32800530 Free article. Review.
Human NK cells, their receptors and function.
Quatrini L, Della Chiesa M, Sivori S, Mingari MC, Pende D, Moretta L. Quatrini L, et al. Among authors: sivori s. Eur J Immunol. 2021 Jul;51(7):1566-1579. doi: 10.1002/eji.202049028. Epub 2021 May 10. Eur J Immunol. 2021. PMID: 33899224 Free PMC article. Review.
Editorial: Natural Killer Cells in Tissue Compartments.
Vitale M, Caligiuri MA, Sivori S. Vitale M, et al. Among authors: sivori s. Front Immunol. 2020 Feb 20;11:258. doi: 10.3389/fimmu.2020.00258. eCollection 2020. Front Immunol. 2020. PMID: 32153578 Free PMC article. No abstract available.
NK Cell-Based Immunotherapy in Colorectal Cancer.
Della Chiesa M, Setti C, Giordano C, Obino V, Greppi M, Pesce S, Marcenaro E, Rutigliani M, Provinciali N, Paleari L, DeCensi A, Sivori S, Carlomagno S. Della Chiesa M, et al. Among authors: sivori s. Vaccines (Basel). 2022 Jun 28;10(7):1033. doi: 10.3390/vaccines10071033. Vaccines (Basel). 2022. PMID: 35891197 Free PMC article. Review.
Harnessing NK Cells for Cancer Treatment.
Minetto P, Guolo F, Pesce S, Greppi M, Obino V, Ferretti E, Sivori S, Genova C, Lemoli RM, Marcenaro E. Minetto P, et al. Among authors: sivori s. Front Immunol. 2019 Dec 6;10:2836. doi: 10.3389/fimmu.2019.02836. eCollection 2019. Front Immunol. 2019. PMID: 31867006 Free PMC article. Review.
CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma.
Gambella M, Carlomagno S, Raiola AM, Giannoni L, Ghiggi C, Setti C, Giordano C, Luchetti S, Serio A, Bo A, Falco M, Della Chiesa M, Angelucci E, Sivori S. Gambella M, et al. Among authors: sivori s. Front Immunol. 2022 Feb 24;13:837457. doi: 10.3389/fimmu.2022.837457. eCollection 2022. Front Immunol. 2022. PMID: 35280988 Free PMC article. Review.
NK Cell-Based Immunotherapy for Hematological Malignancies.
Sivori S, Meazza R, Quintarelli C, Carlomagno S, Della Chiesa M, Falco M, Moretta L, Locatelli F, Pende D. Sivori S, et al. J Clin Med. 2019 Oct 16;8(10):1702. doi: 10.3390/jcm8101702. J Clin Med. 2019. PMID: 31623224 Free PMC article. Review.
NK/DC crosstalk in anti-viral response.
Marcenaro E, Carlomagno S, Pesce S, Moretta A, Sivori S. Marcenaro E, et al. Among authors: sivori s. Adv Exp Med Biol. 2012;946:295-308. doi: 10.1007/978-1-4614-0106-3_17. Adv Exp Med Biol. 2012. PMID: 21948375 Review.
TLR/NCR/KIR: Which One to Use and When?
Sivori S, Carlomagno S, Pesce S, Moretta A, Vitale M, Marcenaro E. Sivori S, et al. Front Immunol. 2014 Mar 19;5:105. doi: 10.3389/fimmu.2014.00105. eCollection 2014. Front Immunol. 2014. PMID: 24678311 Free PMC article. Review.
61 results